Pill Connect secures £0.5m to take electronic smart pill bottle that monitors patient adherence to commercial launch

Pill Connect, formerly known as Elucid mHealth, has completed a £510,000 funding round which will enable it to complete development of the design, electronics and software for submission to the regulatory authorities in both Europe and the US and continue through to commercial launch.

4D Path Announces Patented Precision Oncology Platform for Instant Biomarker Profiling and Stratification Just From H&E Biopsy or Resection Images

The Platform Allows Pharmaceutical and Biopharmaceutical Companies as well as Clinics and Hospitals to Dramatically Accelerate Precise Cancer Diagnosis for Expediting Clinical Trials and Personalized Therapy

Watson-Marlow Limited Ireland announces plans for new facility in Cork

Watson-Marlow Limited Ireland, award winning, global leader in fluid management technology, will open a state-of-the-art facility in Cork, Ireland. The new ISO 14644-1 Class 7 cleanroom will be added to the company’s existing Cork site and will be certified to meet the demands of the highly regulated pharmaceutical and biopharmaceutical manufacturing sector in Ireland.

Stelis starts next phase of investment into its biologics manufacturing facility

Shimmer Research Wins 2020 Best of Sensors Award for its Verisense Wearable Sensing Platform Developed Specifically for Clinical Trials

The Verisense platform provides complete, high quality, reproducible clinical trial data, while placing minimum burden on sponsors, CROs, site staff and participants.

Scilligence Partners with CAS to Optimize R&D Informatics Workflows with Scientist-Curated Data

Scilligence informatics platform users now have the ability to access CAS’s high-quality scientific content directly in our web-based informatics solutions, including Scilligence Inventory and Scilligence ELN.

CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing innovation

CMO growth hampered by innovator approvals from mega cap pharma, yet contract clinical and recombinant vector manufacturing growing in demand

Ardigen and BioCollective partner to detect early signs of Parkinson’s Disease for better diagnosis and treatment

Ardigen and The BioCollective today announced a research collaboration aimed at the development of the world’s first microbiome-based biomarker candidates for Parkinson’s Disease.

Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer

The Medication Adherence Expertise Center and Pill Connect’s smart adherence system help patients with TB take their medication regularly

A pilot trial at The Medication Adherence Expertise Center of the University Medical Center Groningen in the Netherlands is determining whether Pill Connect’s smart bottle system can support patients with tuberculosis (TB) with their medication adherence.

Healthcare agency Page & Page and Partners welcomes wave of new talent

Page & Page and Partners, the global creative communications agency specialising in health, wellness and lifestyle, is today announcing the appointment of three new staff members joining the team on a full time basis. The new joiners are: • Asma Shirazi - Account Director • Emily Sidlow - Senior Account Manager • Isabelle Nicholson-Rose - Account Executive They will all be joining the Client Services team, headed by Rachel Harris and will be working on clients including Novartis, Abbott Diagnostics, Fresenius Kabi, L&R, Align Technology and IQVIA.

FDA Grants Breakthrough Designation to 4D Path for Novel Cancer Diagnostic Solution

Potential for a New Standard of Care to Improve Diagnostic Accuracy for Breast Cancer Exclusively from H&E Biopsy/Resection Images

AVIA Names John Fiacco as Chief Growth Officer

Dotmatics collaborates with LabVoice to enable voice-assisted laboratory workflows

Dyadic C1 protein expression platform explored in fight against COVID-19

JUPITER, FL, UNITED STATES - Oct 30, 2020 - Dyadic International, Inc. (NASDAQ: DYAI) a leading biotechnology innovator focused on accelerating the development and lowering the manufacturing costs of vaccines and biopharmaceuticals, recently announced results which further support record expression levels of the SARS-CoV-2 Receptor Binding Domain (RBD) antigen produced from Dyadic’s industrially proven proprietary & patented hyper-productive C1 gene expression platform

Muscular Dystrophy Association Launches MOVR Visualization and Reporting Platform to Improve Patient Care and Accelerate Drug Discovery

NEW YORK, NY, UNITED STATES - Oct 29, 2020 - The Muscular Dystrophy Association (MDA) announced today the launch of the neuroMuscular ObserVational Research (MOVR) Visualization and Reporting Platform (VRP)

Plus Therapeutics Announces Initiation of Final Cohort of ReSPECT™ Glioblastoma Trial

AUSTIN, TX - Oct 29, 2020 - Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has treated the first patient in the sixth and final cohort of its National Cancer Institute (NCI)-supported, multi-center ReSPECT™ Phase 1 dose-finding clinical trial evaluating Rhenium NanoLiposomes (RNL™) for the treatment of recurrent glioblastoma (GBM)

7th Crystal Structure Prediction Blind Test brings new challenges for computational chemists

CAMBRIDGE, UNITED KINGDOM - Oct 28, 2020 - Announcing the new challengeThis week the 7th CSP Blind Test begins - a major challenge in computational chemistry

OmniTier Streamlines Personalized Medicine Workflows with CompStor Insight™ for Next-Generation Sequencing Tertiary Analysis

MILPITAS, CA, UNITED STATES - Oct 27, 2020 - OmniTier Inc., an AI and multiomics application company whose bioinformatics solutions help deliver the promise of personalized medicine, debuted the CompStor Insight™ appliance for tertiary analysis in next-generation sequencing (NGS) applications

Vidence And 2bPrecise Announce Strategic Partnership To Unleash The Power Of Genomic Data In Precision Oncology

RALEIGH, NC, UNITED STATES - Oct 27, 2020 - Vidence, an oncology informatics company, has selected the 2bPrecise™ platform, a precision medicine data delivery solution, to make it easier for its Consortium Fellows to unlock the true power of genomic data at the point of care and facilitate the advancement of precision oncology